Table 3.

Odds Ratio of Individual Stroke Symptoms by Biomarkers in the Fourth versus First Quartile

	Individual Stroke Symptoms
Biomarker	Unilateral numbness (n=77)	Unilateral painless weakness (n=66)	Painless loss of vision in one or both eyes (n=51)
Cardiac Function
NT-proBNP, pg/mL
Model 1	1.36 (0.66, 2.82)	1.54 (0.66, 3.57)	1.22 (0.51, 2.91)
Model 2	1.52 (0.66, 3.48)	0.95 (0.36, 2.50)	1.23 (0.49, 3.09)
Inflammation
Fibrinogen, mg/dL
Model 1	0.79 (0.43, 1.42)	1.41 (0.72, 2.75)	1.19 (0.57, 2.49)
Model 2	0.72 (0.37, 1.39)	1.06 (0.51, 2.20)	1.23 (0.53, 2.83)
CRP, mg/L
Model 1	2.42 (1.18, 4.96)	1.77 (0.82, 3.81)	4.39 (1.88, 10.23)
Model 2	2.45 (1.09, 5.51)	1.53 (0.66, 3.56)	4.83 (1.91, 12.19)
Coagulation
FXI, %
Model 1	1.19 (0.62, 2.30)	1.97 (0.88, 4.39)	1.16 (0.54, 2.49)
Model 2	1.18 (0.56, 2.48)	1.77 (0.76, 4.15)	1.19 (0.47, 3.00)
D-dimer, μg/mL
Model 1	1.93 (0.98, 3.82)	2.94 (1.31, 6.59)	2.57 (0.96, 6.89)
Model 2	2.11 (0.99, 4.52)	3.74 (1.48, 9.43)	2.27 (0.82, 6.28)

Model 1 Adjusted for age, race and sex.

Model 2 Adjusted for age, race, sex, history of heart disease, atrial fibrillation, diabetes mellitus, antihypertensive medication use, current smoking, systolic blood pressure, LVH, lipid lowering medication use and regular aspirin use